Update information

September 2025: We have reviewed the evidence on treating and monitoring heart failure with reduced ejection fraction, mildly reduced ejection fraction and preserved ejection fraction. Recommendations are marked [2025] if the evidence has been reviewed.

September 2018: This guideline updates and replaces NICE guideline CG108 (published August 2010). NICE guideline CG108 updated and replaced NICE guideline CG5 (published July 2003).

Minor changes since publication

October 2025: We amended the rationale for recommendation 1.7.10 to clarify that an ECG should be carried out before prescribing a beta-blocker.

November 2021: We added links to NICE's guideline on heart valve disease.

ISBN: 978-1-4731-7169-5